Skip to main content

XBiotech Inc.

corporate_fare Company Profile

XBiotech Inc.

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed XBIT - Latest Insights

XBIT
Apr 29, 2026, 1:02 PM EDT
Filing Type: 10-K/A
Importance Score:
9
XBIT
Mar 13, 2026, 2:33 PM EDT
Filing Type: 10-K
Importance Score:
8